| 1 |
32139666 | Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s. | 2020 Mar 5 |
3 |
| 2 |
25367763 | Differential impact of bortezomib on HL-60 and K562 cells. | 2015 Jan |
2 |
| 3 |
24407159 | Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro. | 2014 Apr |
2 |
| 4 |
25153785 | Combined inhibition of Hsp90 and the proteasome affects NSCLC proteostasis and attenuates cell migration. | 2014 Oct |
1 |
| 5 |
23256542 | Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia. | 2013 Sep |
1 |
| 6 |
22120110 | Identification of HSP90 as a new GABARAPL1 (GEC1)-interacting protein. | 2012 Mar |
1 |
| 7 |
22562379 | Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naïve T-cell subtypes. | 2012 Nov |
1 |
| 8 |
21106982 | The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78. | 2011 Jan 27 |
4 |
| 9 |
21219297 | Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers. | 2011 Feb |
1 |
| 10 |
21534941 | Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study. | 2011 Jun |
1 |
| 11 |
20416171 | [Correlation of HSP90 mRNA expression with migration ability of human multiple myeloma cells]. | 2010 Apr |
2 |
| 12 |
17299090 | Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. | 2007 Jun 1 |
6 |
| 13 |
17721082 | Towards a better way to die with chemotherapy: role of heat shock protein exposure on dying tumor cells. | 2007 Aug 15 |
2 |
| 14 |
16234364 | Antimyeloma activity of heat shock protein-90 inhibition. | 2006 Feb 1 |
1 |
| 15 |
16846475 | Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib. | 2006 Jul |
1 |
| 16 |
16966435 | Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade. | 2006 Sep |
1 |
| 17 |
15141013 | Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. | 2004 May |
2 |